Artículos del autor

solaci

Day 3

Mitral valve repair in moderate ischemic mitral regurgitation

Article Up to 50% of acute myocardial infarctions are associated to mitral regurgitation of some degree and 10%...
solaci -
Day 3

INHERIT: Losartan in hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is the most common hereditary cardiac pathology (1/1500) and is associated to heart failure, angina,...
solaci -
Day 3

Reducing antibiotic prophylaxis: impact on endocarditis incidence.

Antibiotic prophylaxis before dental procedures has been the gold standard in preventing infective endocarditis, despite the lack...
solaci -
Day 3

Atenolol vs. Losartan in children and young adults with Marfan syndrome

Article Aortic root dissection is the main cause of mortality in Marfan syndrome. Recent studies suggest that losartan...
solaci -
Day 2

IMPROVE-IT Trial: Finally the association of ezetimibe and simvastatin reduces events vs. simvastatin monotherapy

This is a multicenter, randomized, double blind study designed to test the hypothesis that the combination of...
solaci -
Day 2

FACTOR 64: Routine coronary CT angiography in patients at high risk for heart disease.

Article 900 patients with asymptomatic diabetes mellitus were randomized to CT angiography vs. Standard management. Primary end point...
solaci -
Day 2

ODYSSEY ALTERNATIVE: Monoclonal antibody alirocumab vs. ezetimibe in patients with statin intolerance

Statin intolerance limits patients’ capacity to reach their LDL goals. This study compared the new drug alirocumab...
solaci -
Day 2

Low doses of aspirin for primary prevention in elderly patients with multiple risk factors.

Article The goal of this study was to assess the efficacy of low doses of aspirin (AAS) for...
solaci -